Skip to content
Research Article Open access CC BY 3.0

Efficacy of Long-term Effect and Repeat Intraarticular Botulinum toxin in Patients with Painful Total Joint Arthroplasty: A Retrospective Study

Jasvinder A. Singh

Journal of Advances in Medicine and Medical Research · pp. 139–148 · Published 14 Sep 2013

10.9734/BJMMR/2014/4897

Abstract

Objective: Based on recent success of intra-articular (IA) Botulinum neurotoxin type A (BoNT/A; OnabotulinumtoxinA) in patients with osteoarthritis, we examined if repeat IA-BoNT/A is an effective antinociceptive in patients with refractory arthroplasty pain. Methods: 11 patients with refractory chronic arthroplasty joint pain without any evidence of infection or prosthesis loosening were referred by orthopedic surgeons. After discussion of off-label use, each patient underwent IA injection of BoNT/A, repeated based on return of pain on numeric rating scale (NRS) and functional limitation on composite validated scales, Western Ontario McMaster Osteoarthritis index (WOMAC) or Shoulder Pain and Disability (SPADI). Results: 11 patients (10 men, 1 woman) with 14 painful arthroplasty joints (3 bilateral; 12 knee and 2 shoulder) underwent ≥1 IA-BoNT/A injections (8 joints injected once, one joint injected twice only, five joints injected thrice) with doses ranging 100-300 units. Mean age was 68 years (standard deviation, 12) and follow-up ranged 1-28 months. Clinically meaningful reduction of 2-units in pain severity and really meaningful reduction in pain severity (50% reduction) were reported by 6/11 patients (6/13 joints) and 3/11 patients (3/13 joints), respectively, 1 month after the first IA-BoNT/A (100-units each). Significant improvements were noted in composite functional scales (WOMAC/SPADI). Pain relief was sustained at 3-4 month follow-up and was reproducible in those who received repeat injections. No significant adverse events were seen in any patients. Conclusions: A single intra-articular injection of BoNT/A improved pain and function in patients with chronic, refractory painful knee or shoulder arthroplasty, which sustained with repeat injections. Patients, who were refractory to the first injection, did not respond to subsequent injections of higher dose of IA-BoNT/A.

Intraarticular botulinum toxin total joint arthroplasty pain function

References (17)

  1. 1 Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030 [DOI]
  2. 2 Development of a Shoulder Pain and Disability Index [DOI]
  3. 3 Ranawat Award Paper: Predicting Total Knee Replacement Pain [DOI]
  4. 4 Clinically Important Changes in Acute Pain Outcome Measures [DOI]
  5. 5 Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential [DOI]
  6. 6 Botulinum toxin injections for cervical dystonia [DOI]
  7. 7 Long term effects of intra-articular botulinum toxin a for refractory joint pain [DOI]
  8. 8 Botulinum neurotoxins in the treatment of refractory pain [DOI]
  9. 9 Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial [DOI]
  10. 10 Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis.
  11. 11 Intraarticular Botulinum Toxin A for Refractory Painful Total Knee Arthroplasty: A Randomized Controlled Trial [DOI]
  12. 12 Intra-articular Botulinum Toxin Type A: A new approach to treat arthritis joint pain [DOI]
  13. 13 Evidence-based medicine: botulinum toxin A in migraine and tension-type headache [DOI]
  14. 14 Botulinum toxin therapy for osteoarticular pain: an evidence-based review [DOI]
  15. 15 Variations in Current Manual Muscle Testing [DOI]
  16. 16 Sensory nerves in the interface membrane of aseptic loose hip prostheses [DOI]
  17. 17 Substance P Level In Synovial Fluid May Predict Pain Relief After Knee Replacement [DOI]

Cited by 20

Pain Modulation in Chronic Musculoskeletal Disorders: Botulinum Toxin, a Descriptive Analysis.

Poenaru D, Sandulescu MI, Cinteza D. · Biomedicines · 2023

Comparison between intra-articular Botulinum toxin type A, corticosteroid, and saline in knee osteoarthritis: a randomized controlled trial.

Mendes JG, Natour J, Nunes-Tamashiro JC · Clin Rehabil · 2019

Intra-articular botulinum toxin A (BoNT/A) for pain management in dogs with osteoarthritis secondary to hip dysplasia: A randomized controlled clinical trial.

Nicácio GM, Luna SPL, Cavaleti P · J Vet Med Sci · 2019

Beyond the muscular effects - onabotulinumtoxinA injections for pain control in chronic knee osteoarthritis: a case report.

Ko GD, Lam KI, Looi J · J Pain Res · 2018

Intra-articular onabotulinumtoxinA in osteoarthritis knee pain: effect on human mechanistic pain biomarkers and clinical pain.

Arendt-Nielsen L, Jiang GL, DeGryse R · Scand J Rheumatol · 2017

Botulinum neurotoxin type A versus punctal plug insertion in the management of dry eye disease.

Bukhari AA. · Oman J Ophthalmol · 2014

Showing 6 of 20 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

10

Page views

0

PDF downloads

0

Outbound clicks

20

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.